Putting Menopausal Hormone Therapy – HT- Back on the Table

HRT-white-pillsLeslie Carol Botha:  Consumer beware.. hormone therapy, menopause management, hormone replacement therapy is one in the same.  If women were educated about their endocrine system functioning and the vital role that nutrients and hormones play in our everyday health, there would be very little need for ‘menopause management’.

I, for one, am miffed by the statement that the “controversies and misrepresentations (about HT) have ‘impeded’ women’s abilities to make choices about their own healthcare.” I think what they are really saying is that the acknowledgement that hormone therapy’s risks vs. benefits have ‘impeded’ the pharmaceutical company’s management of their profit line.

This is obviously a ploy to market HT to a new market of users: “younger postmenopausal women.”  Us older “postmenopausal women” are filing lawsuits against Pharma for the breast cancer we developed after taking HRT – hormone replacement therapy.

New market – new name – but the premise still stands: estrogen is to cancer as fertilizer is to wheat.

SWHR Advocates Returning Decision Power to Women for Menopausal Hormone Therapy

It’s time to put HT back on the table so that women can discuss with their providers the option of symptom relief and possible long term health benefits.

The Society for Women’s Health Research (SWHR) revealed today in The Journal of Women’s Health, the results of their expert, international roundtable on Menopausal Hormone Therapy (HT), illuminating the controversies and misrepresentations that have impeded women’s abilities to make choices about their own healthcare.

Washington, DC (PRWEB) April 16, 2013

The Society for Women’s Health Research (SWHR) revealed today in The Journal of Women’s Health, the results of their expert, international roundtable on Menopausal Hormone Therapy (HT), illuminating the controversies and misrepresentations that have impeded women’s abilities to make choices about their own healthcare.

Women suffer from menopausal symptoms, perhaps needlessly, without the opportunity to determine for themselves whether the long term risks outweigh the potential benefit of HT. SWHR convened the roundtable of menopause experts to address the data across decades of research studies and to discuss how interpretations of the data have impacted women’s health.

Their findings include:

  • In younger, postmenopausal women with menopausal symptoms, the benefits of HT outweigh the risks;
  • HT is the most effective treatment for osteoporosis and should be considered for the prevention of osteoporosis, especially among at risk women;
  • Contrary to popular misconceptions, HT for early, postmenopausal women does not increase the risk for coronary heart disease (CHD) and may even reduce it;
  • HT does not increase total mortality rates and may, in fact reduce them.

Symptoms associated with the onset of menopause, such as night sweats and hot flashes, can be severe and may have major impacts on a woman’s quality of life. HT is the only effective, FDA approved treatment for the management of these symptoms. However, a decade of controversial and contradictory study reports on the risks and benefits of HT on long-term outcomes, such as breast cancer and cardiovascular disease, has led to reactionary and negative press and policy decisions. As a result, the public has been led to believe that HT presents a major health risk and consideration of HT for menopausal symptom relief has been, effectively, taken off of the table for a majority of doctors and their patients.

The importance of this roundtable and their findings is made evident through recent published reports on whether HT treatment places women at increased risk of developing breast cancer. These form the latest in a long line of reports with conflicting results over the risks/benefits of HT on the development of breast cancer, all of which debate whether very small increases or decreases (ex. 0.14% in the latest report) constitute a tangible threat to women. SWHR argues that women should be given the facts to make their own decisions, and provides the data in their report.

Read full press release…

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.